Voting Rights and Capital: Month End Disclosure

3 January 2018

Arix Bioscience plc

Voting Rights and Capital: Month End Disclosure

Pursuant to Disclosure and Transparency Rule 5.6.1:

As at 31 December 2017, the issued share capital of Arix Bioscience plc comprised 96,153,090 ordinary shares of £0.00001 each and 49,671 non-voting C Shares of £1.00 each. There were no shares held in treasury.

The total number of voting rights in Arix Bioscience plc was therefore 96,153,090.

The total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Arix Bioscience plc under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

James Rawlingson Chief Financial Officer +44 (0)207 290 1050

- Ends -